Open AccessP1457: DEMOGRAPHICS AND TREATMENT OUTCOMES IN PATIENTS WITH EBV+ PTLD TREATED WITH OFF‐THE‐SHELF EBV‐SPECIFIC CTL (TABELECLEUCEL) UNDER AN ONGOING EXPANDED ACCESS PROGRAM IN EUROPE: FIRST ANALYSES
Author(s) -
Choquet S.,
Uttenthal B.,
Chaganti S.,
Comoli P.,
Trappe R.,
Friedetzky A.,
Xing B.,
Li X.,
Polak T.,
Gamelin L.,
Terwey J.H.,
Dierickx D.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848684.24968.42
Subject(s) - medicine , rituximab , demographics , malignancy , post transplant lymphoproliferative disorder , epstein–barr virus , oncology , lymphoproliferative disorders , lymphoma , immunology , virus , demography , sociology